Christopher T Su
10PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|May 15, 2024
Mitigating time toxicity in lymphoma and multiple myeloma.Mengyang Di, Christopher T Su, Andrew J Cowan
|Nov 16, 2022
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.Christopher T Su, Emily Nizialek, Jacob E Berchuck
|Apr 12, 2022
Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020.Christopher T Su, Christine M Veenstra, Minal R Patel
|Mar 09, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch
|Dec 09, 2021
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.Vadim S Koshkin, Nicholas Henderson, Marihella James
|Nov 15, 2021
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.Fadi Taza, Albert E Holler, Wei Fu
Pageof 2
Frequent Collaborators
2 joint publications
Vadim S Koshkin
2 joint publications
Heather H Cheng
2 joint publications
Alexandra Sokolova
2 joint publications
Panagiotis J Vlachostergios
2 joint publications
Jacob E Berchuck
2 joint publications
Alan H Bryce
2 joint publications
Pedro C Barata
2 joint publications
Oliver Sartor
1 joint publications
Rahul Banerjee
1 joint publications
Albert E Holler
